197 related articles for article (PubMed ID: 30050594)
1. Prognostic Impact of CEACAM1 in Node-Negative Ovarian Cancer Patients.
Oliveira-Ferrer L; Goswami R; Galatenko V; Ding Y; Eylmann K; Legler K; Kürti S; Schmalfeldt B; Milde-Langosch K
Dis Markers; 2018; 2018():6714287. PubMed ID: 30050594
[TBL] [Abstract][Full Text] [Related]
2. CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease.
Thies A; Moll I; Berger J; Wagener C; Brümmer J; Schulze HJ; Brunner G; Schumacher U
J Clin Oncol; 2002 May; 20(10):2530-6. PubMed ID: 12011132
[TBL] [Abstract][Full Text] [Related]
3. Neutrophils infiltration in the tongue squamous cell carcinoma and its correlation with CEACAM1 expression on tumor cells.
Wang N; Feng Y; Wang Q; Liu S; Xiang L; Sun M; Zhang X; Liu G; Qu X; Wei F
PLoS One; 2014; 9(2):e89991. PubMed ID: 24587171
[TBL] [Abstract][Full Text] [Related]
4. Loss of membranous carcinoembryonic antigen-related cell adhesion molecule 1 expression is related to decreased relapse-free survival of hepatocellular carcinoma following liver transplantation.
Sha QQ; Wei QZ; Zhu JK; Wang KX; Wang C; Liu HT; Yu WB; Li MX; Zhang GY
Chin Med J (Engl); 2012 Aug; 125(16):2841-5. PubMed ID: 22932077
[TBL] [Abstract][Full Text] [Related]
5. Carcinoembryonic antigen-related cell adhesion molecule 1a-4L suppression of rat hepatocellular carcinomas.
Laurie NA; Comegys MM; Carreiro MP; Brown JF; Flanagan DL; Brilliant KE; Hixson DC
Cancer Res; 2005 Dec; 65(23):11010-7. PubMed ID: 16322250
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of carcinoembryonic antigen-related cell adhesion molecule 1 in gastrointestinal cancer and its clinical relevance.
Zhou M; Jin Z; Liu Y; He Y; Du Y; Yang C; Wang Y; Hu J; Cui L; Gao F; Cao M
Acta Biochim Biophys Sin (Shanghai); 2017 Aug; 49(8):737-743. PubMed ID: 28655144
[TBL] [Abstract][Full Text] [Related]
7. Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers.
Luebke AM; Ricken W; Kluth M; Hube-Magg C; Schroeder C; Büscheck F; Möller K; Dum D; Höflmayer D; Weidemann S; Fraune C; Hinsch A; Wittmer C; Schlomm T; Huland H; Heinzer H; Graefen M; Haese A; Minner S; Simon R; Sauter G; Wilczak W; Meiners J
Int J Cancer; 2020 Jul; 147(2):575-583. PubMed ID: 32150281
[TBL] [Abstract][Full Text] [Related]
8. CEACAM1 is associated with recurrence after hepatectomy for colorectal liver metastasis.
Yamaguchi S; Yokoyama S; Ueno M; Hayami S; Mitani Y; Takeuchi A; Shively JE; Yamaue H
J Surg Res; 2017 Dec; 220():353-362. PubMed ID: 29180203
[TBL] [Abstract][Full Text] [Related]
9. Correlation between immunohistochemical staining of CEACAM1 and clinicopathological findings in oral pre-neoplastic lesions and squamous cell carcinoma.
Simonetti O; Lucarini G; Rubini C; Zizzi A; Aspriello SD; Di Primio R; Offidani AM
Med Mol Morphol; 2018 Mar; 51(1):41-47. PubMed ID: 28887602
[TBL] [Abstract][Full Text] [Related]
10. Carcinoembryonic antigen-related cell adhesion molecule 1 is expressed and as a function histotype in ovarian tumors.
Li N; Yang JY; Wang XY; Wang HT; Guan BX; Zhou CJ
Ann Diagn Pathol; 2016 Feb; 20():7-12. PubMed ID: 26653024
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen cell adhesion molecule 1 inhibits the antitumor effect of neutrophils in tongue squamous cell carcinoma.
Wang N; Wang Q; Chi J; Xiang F; Lin M; Wang W; Wei F; Feng Y
Cancer Sci; 2019 Feb; 110(2):519-529. PubMed ID: 30565803
[TBL] [Abstract][Full Text] [Related]
12. Re-expression of CEACAM1 long cytoplasmic domain isoform is associated with invasion and migration of colorectal cancer.
Ieda J; Yokoyama S; Tamura K; Takifuji K; Hotta T; Matsuda K; Oku Y; Nasu T; Kiriyama S; Yamamoto N; Nakamura Y; Shively JE; Yamaue H
Int J Cancer; 2011 Sep; 129(6):1351-61. PubMed ID: 21413011
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implication of CEACAM1 expression in squamous cell carcinoma of the larynx: Pilot study.
Lucarini G; Zizzi A; Re M; Sayeed MA; Di Primio R; Rubini C
Head Neck; 2019 Jun; 41(6):1615-1621. PubMed ID: 30582236
[TBL] [Abstract][Full Text] [Related]
14. CEACAM1 controls the EMT switch in murine mammary carcinoma in vitro and in vivo.
Wegwitz F; Lenfert E; Gerstel D; von Ehrenstein L; Einhoff J; Schmidt G; Logsdon M; Brandner J; Tiegs G; Beauchemin N; Wagener C; Deppert W; Horst AK
Oncotarget; 2016 Sep; 7(39):63730-63746. PubMed ID: 27572314
[TBL] [Abstract][Full Text] [Related]
15. The transmembrane domain of CEACAM1-4S is a determinant of anchorage independent growth and tumorigenicity.
Lawson EL; Mills DR; Brilliant KE; Hixson DC
PLoS One; 2012; 7(1):e29606. PubMed ID: 22235309
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma.
Darb-Esfahani S; Kunze CA; Kulbe H; Sehouli J; Wienert S; Lindner J; Budczies J; Bockmayr M; Dietel M; Denkert C; Braicu I; Jöhrens K
Oncotarget; 2016 Jan; 7(2):1486-99. PubMed ID: 26625204
[TBL] [Abstract][Full Text] [Related]
17. Functional role and prognostic significance of CD157 in ovarian carcinoma.
Ortolan E; Arisio R; Morone S; Bovino P; Lo-Buono N; Nacci G; Parrotta R; Katsaros D; Rapa I; Migliaretti G; Ferrero E; Volante M; Funaro A
J Natl Cancer Inst; 2010 Aug; 102(15):1160-77. PubMed ID: 20639476
[TBL] [Abstract][Full Text] [Related]
18. Expression of CEACAM1 in adenocarcinoma of the lung: a factor of independent prognostic significance.
Laack E; Nikbakht H; Peters A; Kugler C; Jasiewicz Y; Edler L; Brümmer J; Schumacher U; Hossfeld DK
J Clin Oncol; 2002 Nov; 20(21):4279-84. PubMed ID: 12409325
[TBL] [Abstract][Full Text] [Related]
19. CEACAM1 long cytoplasmic domain isoform is associated with invasion and recurrence of hepatocellular carcinoma.
Kiriyama S; Yokoyama S; Ueno M; Hayami S; Ieda J; Yamamoto N; Yamaguchi S; Mitani Y; Nakamura Y; Tani M; Mishra L; Shively JE; Yamaue H
Ann Surg Oncol; 2014 Dec; 21 Suppl 4(0 4):S505-14. PubMed ID: 24390710
[TBL] [Abstract][Full Text] [Related]
20. Loss/Down-regulation of tumor suppressor in lung cancer 1 expression is associated with tumor progression and is a biomarker of poor prognosis in ovarian carcinoma.
Yang G; He W; Cai M; Luo F; Kung H; Guan X; Zeng Y; Xie D
Int J Gynecol Cancer; 2011 Apr; 21(3):486-93. PubMed ID: 21436696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
